Celldex Therapeutics, Inc.
CLDX· Nasdaq
Released Aug 6, 2013, during market hours
10-Q filed Aug 6, 2013, 37 days after period end · 0001104659-13-060226
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2013 | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|---|
| Revenue | $97.00K | $2.01M | $1.95M | $2.95M |
| Net Income | — | — | -$10.24M | -$9.53M |
| EPS Diluted | -$0.24 | -$0.23 |
Celldex Therapeutics, Inc. · CIK 744218 · Engraved from SEC EDGAR
| -$0.27 |
| -$0.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.